Drug Company Aid Programs

As a matter of policy most pharmaceutical companies prefer to have their Myeloma patients apply to non-profit copay foundations for the financial aid money used to help pay for their drugs.

UPDATE: Financial Aid – Updated January 19, 2017
The Patient Advocate Foundation’s Co-Pay Relief Fund has changed the Status of Myeloma to OPEN.  The program’s maximum award level $10,000 annually.  This is for patients with Medicare, Medicaid, or Military Benefits only. The PAF Myeloma Page can be found  HERE.

The Leukemia & Lymphoma Society (LLS) Co-Pay Assistance Program has changed the Status of Myeloma to OPEN. The program’s maximum award level $7,500 annually for insurance premiums, co-pay, co-insurance, and medical & prescription deductibles. The LLS Myeloma page can be found The LLS Myeloma page can be found here HERE.

The Patient Access Network Foundation (PAN) is again OPEN to myeloma patients.  The program’s maximum award level $8,400 annually for assistance with insurance premiums, co-payments, co-insurance and deductibles. The Patient Access Network Myeloma page can be found HERE.

As of this week the Healthwell Fouindation is again closed.  The Assistance Fund, CancerCare, and Good Days/Chronic Disease Fund remain closed to Myeloma patients.

Please contact us if you become aware of any new programs or of any existing program re-opening.  At times like this we truly need to live up to our “Support” group mission.


Even though some patient co-pay foundations have re-opened for 2018 it is still good to be aware of the drug manufactures own financial aid programs, particularly if your application is denied by a foundation.

Celgene’s (Thalomid, Revlimid, & Pamalyst) patient support web portal can be found at:

Takeda Financial Aid
Ninlaro 1Point Program:  https://www.ninlaro.com/cost
Velcade Support: http://www.velcade.com/paying-for-treatment/

Amgen Kyprolis
Amgen Assist 360 Program: http://www.amgenassist360.com/patient/kyprolis-cost-nurse-ambassador-assistance/

Janssen Darzalex
Janssen CarePath Program: https://www.darzalexhcp.com/cost-support/janssen-carepath#affordability

Bristol-Myers Squibb Empliciti (elotuzumab)
Bristol-Myers Squibb Access Support: https://www.darzalexhcp.com/cost-support/janssen-carepath#affordability

More to come (I’m sure).

2017 Health & Human Services Poverty Guidelines & Dollar Figures for 100%, Medicaid Eligibility (at 138%), 400% and 500% above the Federal Poverty Guidelines

100% Medicaid Eligibility (138% of FPL) 400% 500%
1 $12,060 $16,643 $48,240 $60,300
2 $16,240 $22,411 $64,960 $81,200
3 $20,420 $28,180 $81,680 $102,100
4 $24,600 $33,948 $98,400 $123000
5 $28,780 $39,716 $115,120 $143,900
6 $32,960 $45,485 $131,840 $164,800
7 $37,140 $51,253 $148,560 $185,700
8 $41,320 $57,022 $165,280 $206,600